Analyst Ratings for Affimed Therapeutics (AFMD)

AFMD Rating Summary

  |   Expand Research on AFMD
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.9 / 10   Percentile Rank: 74%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/14/2025 Cantor Fitzgerald Li Watsek Downgrade Neutral
(Overweight)		 N/A
(N/A)		 0.13
(0.18)		 38.46% Details
5/14/2025 H.C. Wainwright Swayampakula Ramakanth Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.13
(0.18)		 38.46% Details